These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 3522246

  • 1. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M, Hammarström ML, Hammarström S, Hellström U, Perlmann P.
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [Abstract] [Full Text] [Related]

  • 2. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
    Perl A, Looney RJ, Ryan DH, Abraham GN.
    J Immunol; 1986 Jun 15; 136(12):4714-20. PubMed ID: 3011902
    [Abstract] [Full Text] [Related]

  • 3. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
    Schmidt RE, Caulfield JP, Michon J, Hein A, Kamada MM, MacDermott RP, Stevens RL, Ritz J.
    J Immunol; 1988 Feb 01; 140(3):991-1002. PubMed ID: 3276787
    [Abstract] [Full Text] [Related]

  • 4. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering.
    Platsoucas CD.
    Eur J Immunol; 1984 Jun 01; 14(6):566-77. PubMed ID: 6610558
    [Abstract] [Full Text] [Related]

  • 5. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL, Roozemond RC, van de Griend RJ.
    J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME, Hiserodt JC.
    J Immunol; 1982 Mar 01; 128(3):1246-51. PubMed ID: 6976989
    [Abstract] [Full Text] [Related]

  • 7. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
    Christiaansen JE, Burnside SS, Sears DW.
    J Immunol; 1987 Apr 01; 138(7):2236-43. PubMed ID: 3549899
    [Abstract] [Full Text] [Related]

  • 8. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
    Hommel-Berrey G, Bochan M, Brahmi Z.
    Nat Immun; 1994 Apr 01; 13(6):301-14. PubMed ID: 7894201
    [Abstract] [Full Text] [Related]

  • 9. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
    Aramburu J, Balboa MA, Izquierdo M, López-Botet M.
    J Immunol; 1991 Jul 15; 147(2):714-21. PubMed ID: 1830071
    [Abstract] [Full Text] [Related]

  • 10. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 15; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 11. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME, Kim YB.
    J Immunol; 1990 Jun 01; 144(11):4452-62. PubMed ID: 1971298
    [Abstract] [Full Text] [Related]

  • 12. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA, Van Lier RA, Spits H, Ivanyi P, Melief CJ.
    Eur J Immunol; 1986 Nov 01; 16(11):1363-71. PubMed ID: 2430810
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of proliferative and cytotoxic activities of human T lymphocytes with rabbit antibodies directed against leucoagglutinin-reactive T cell surface components.
    Berzins T, Axelsson B, Hammarström ML, Hammarström S, Perlmann P.
    Eur J Immunol; 1984 Dec 01; 14(12):1145-52. PubMed ID: 6335097
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B, Lebow LT, Bradley TP.
    J Immunol; 1984 Feb 01; 132(2):594-8. PubMed ID: 6606675
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies against SSEA-1 antigen: binding properties and inhibition of human natural killer cell activity against target cells bearing SSEA-1 antigen.
    Harris JF, Chin J, Jewett MA, Kennedy M, Gorczynski RM.
    J Immunol; 1984 May 01; 132(5):2502-9. PubMed ID: 6143780
    [Abstract] [Full Text] [Related]

  • 16. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
    van de Griend RJ, Bolhuis RL, Stoter G, Roozemond RC.
    J Immunol; 1987 May 15; 138(10):3137-44. PubMed ID: 2952709
    [Abstract] [Full Text] [Related]

  • 17. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
    Schmidt RE, Bartley G, Levine H, Schlossman SF, Ritz J.
    J Immunol; 1985 Aug 15; 135(2):1020-5. PubMed ID: 3924996
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.